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Abstract 
Background: Due to the global spread of COVID-19, oncology departments across the world 
rapidly adapted their cancer care protocols, balancing the risk of delaying cancer treatments and 
risk of COVID-19 exposure. COVID-19 and associated changes may have an impact on psycho-
social functioning of cancer patients and survivors. We wanted to understand the impact of 
COVID-19 pandemic on young people living with and beyond cancer. 
 
Method: In this cross-sectional study, we surveyed 177 individuals, aged 18 - 39 years, about 
the impact of COVID-19 on their cancer care and psychological wellbeing. Participants also 
reported their information needs relating to COVID-19. Responses were summarized using 
content analysis approach.  
 
Results: This is the first study to examine psychological functioning of young patients and 
survivors during the first weeks of the COVID-19 pandemic. Close to a third of respondents 
reported increased levels of psychological distress, and as many as 60% reported feeling more 
anxious than they did prior to COVID-19. More than half also wanted more information tailored 
to them as young cancer patients.  
 
Conclusions: The COVID-19 pandemic is rapidly evolving and changing the landscape of 
cancer care. Young people living with cancer are a unique population and might be more 
vulnerable during this time compared to their healthy peers. There is a need to screen for 
psychological distress and attend to young people whose cancer care has been delayed. As the 
lockdown begins to ease, the guidelines about cancer care should be updated according to this 
population’s needs. 
Keywords: COVID-19; survey; depression; anxiety; information needs; adolescent cancer; 
young adult cancer 
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Introduction  
COVID-19 was first identified in China, in December 20191 and is an infectious disease 
caused by the novel SARS-CoV-2 virus.2 In most patients, COVID-19 infection results in mild 
symptoms such as a fever and a dry cough, but in some cases, and particularly in those with 
underlying health conditions and those who are immune compromised, COVID-19 can be more 
severe and can result in serious complications such as Acute Respiratory Distress Syndrome or 
even death.3 To date, findings suggest that COVID-19 poses little threat to children and young 
people,4 however, cancer patients and survivors may be a vulnerable population. Individuals 
undergoing active treatment or taking immunosuppressive medication are known to be at 
higher risk for viral infections,5 while those in survivorship might experience distress due to 
changes in their follow-up care. Most young people living beyond cancer worry about cancer 
recurrence6,7 and resultantly the disrupted follow-up care, which includes physical exams and 
screening may lead to heightened anxiety. As such, adolescent and young adult (AYA) cancer 
patients and survivors remain a group with unique needs during a pandemic outbreak like the 
current COVID-19, even though the relative risk of infection and mortality for this population 
have not yet been established.  
Adolescents and Young Adult (AYA) cancer patients and survivors have been 
recognized as a unique group of patients who face different challenges and needs than their 
younger peers, or older adults.8,9 In response to the global spread of the novel SARS-CoV-2, 
oncology departments quickly acted and adapted measures and protocols for cancer care. Most 
centers sought to balance the risk of delaying cancer treatment with that of exposing a 
vulnerable cancer patient to the virus, which resulted in a crucial reprioritization; the most 
essential and necessary treatments remained on schedule, while early preventative screenings, 
follow-up appointments, and non-essential surgeries were often delayed.10 These changes were 
made rapidly and the newly devised guidelines were operationalized with increased survival in 
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mind, and in hopes to render the oncology centers ‘pandemic proof.’11,12 While taking such 
measures is necessary for successful infection control, the subsequent steps will have to involve 
consideration of the psychological impact of COVID-19 and related changes on cancer 
patients, survivors and their families. 
Even though the scientific, as well as patient support communities were quick to 
recognize the need to provide information about COVID-19 to cancer patients,13 the sudden 
increase and a plethora of resources available was not necessarily tailored to AYA patients’ 
and survivors’ needs. We do not know if the information available is adequate, and if AYAs 
living with or beyond cancer feel confident about making sense of and applying it.  
As after any major global disaster, the COVID-19 pandemic is also likely to result in 
increased mental health symptomatology.14,15 Considering that a subset of AYA cancer patients 
experiences significant levels of psychological distress even under normal circumstances,16,17 
it is important to recognize that worries associated with the pandemic, and any delays in life-
saving treatments are likely to contribute to the anxiety in this population. Furthermore, the 
social distancing measures imposed to contain the spread of the infection may have unintended 
consequences for mental health via changes in social support, economic consequences and 
changes to daily routines.18 In AYAs who are already vulnerable to experiencing distress, this 
may further compound their anxiety.  To ensure that the needs of AYAs continue to be met 
during and after the COVID-19 outbreak, developing new strategies that will help manage, and 
attenuate worries about the COVID-19 exposure should be a priority. This effectively requires 
an understanding of what the needs of AYAs are in this unprecedented context.  
To adapt and better prepare for any future outbreaks, it is important to understand the 
impact of the novel SARS-CoV-2 on AYAs cancer care and their wellbeing. The aim of this 
study was 1) to gather initial evidence of the impact of COVID-19 on AYA cancer patients’ 
and survivors’ psychological well-being and cancer care, and 2) to understand where they 
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received the information about the pandemic and how satisfied they were with the resources 
on COVID-19. 
 
In order to provide the future readership with context, Figure 1 provides an overview with 
all the relevant dates and facts known to the authors at the time of writing this article (May 12, 
2020). 
[INSERT FIGURE 1: Global and UK COVID-19 context at the time of this study.] 
 
 
Method 
This anonymous cross-sectional survey was an extension of an ongoing longitudinal study 
exploring the predictors of psychological well-being and holistic recovery in AYA cancer 
patients. The original study protocol and COVID-19 survey material can be viewed at the 
following link: https://osf.io/ncpv8/.  This study has been approved by the Medical Sciences 
Inter-Divisional Research Ethics Committee at the University of Oxford (R61437/RE005). 
Data were collected using Qualtrics, a secure online survey software, via an anonymous 
link distributed on social media outlets and online via patient organizations’ web posts or 
newsletters. Participants were provided brief information about the study, eligibility criteria, 
and the current aims; understanding what was the COVID-19 impact on their cancer care and 
wellbeing. The survey had two equal arms: a Slovenian and an English, accessible to anyone 
who was able to read and respond in English. Participants were all cancer patients or survivors 
aged between 18 and 39 years, diagnosed with any form of malignant cancer at age 10 or later. 
 
Measures and survey description 
Demographic and Medical information 
Participants reported their age, gender, geographical region, and current living 
arrangement. They also reported their current health status, treatment status, whether or not 
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they had a pre-existing mental health condition or other chronic illness, or if they were taking 
any immunosuppressant medication (i.e. steroids).  
 
Psychological distress  
Psychological distress was measured using the Patient Health Questionnaire for 
Depression and Anxiety (PHQ-4), a 4-item measure of the frequency of two anxiety and two 
depressive symptoms on a 4-point Likert scale from 0 (not at all) to 3 (nearly every day). 
Reliability and validity of the brief PHQ-4 scale have been established in general and clinical 
populations, and a score of 3 or above on either sub-scale, and a total score of 6 or above is 
indicative of clinically relevant distress.19,20 Cronbach’s  for PHQ-4 in our study was 0.84, 
and 0.83 and 0.78 for anxiety and depression subscales, respectively. 
 
COVID-19: impact on care and information resources 
Respondents self-reported if and how the pandemic related events disrupted their cancer 
treatment and care, what the pandemic impact was on their psychological well-being, where 
they received the information about the novel SARS-CoV-2, and how satisfied they were with 
the information available on a scale from 0 (least satisfied/trustworthy) to 10 (most 
satisfied/trustworthy). (See https://osf.io/ncpv8/) 
 
Analysis 
The analyses were conducted in R (Version 3.6.3)21 using the following packages: 
ggplot2 (Version 3.3.0),22  dplyr (Version 0.8.5),23 psych (Version 1.9.12.31)24 and papaja 
(Version 0.1.0.984).25 
Survey data were analysed in an exploratory and descriptive manner in order to provide 
preliminary evidence of the impact of the COVID-19 pandemic on the subjective well-being 
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of cancer patients. We also reported self-reported COVID-19 impact on individuals’ cancer 
treatment protocols. 
Qualitative responses were analysed using content analysis approach.26 The approach 
has been described as suitable for mixed method research, allowing for a more positivistic 
approach to analysis and phenomena description.27 Two researchers (UK, SR) independently 
read and coded all of the responses to open-ended questions about COVID-19 impact on cancer 
patients and caretakers’ psychological well-being. The researchers coded responses, both 
deductively by organizing them around the present study aims and survey questions, as well as 
inductively by devising a list of categories to describe impact on cancer care and the most 
common worries from participants’ descriptions. The formulated categories were refined and 
operationalized into a coherent list upon which all qualitative responses were mapped. The 
inter-rater reliability for this procedure was 96%. Lastly, the classification of responses was 
checked by a third author, and discrepancies were resolved in a consensus meeting. All 
illustrative quotes in the main body are from different participants. 
 
Results 
Participants 
During the period between April 6 and May 12, 2020, 177 AYA cancer patients and 
survivors participated in the study and completed at least 80% of the survey. Of those, 39 were 
from the Slovenian arm and 138 from the English arm. Participants’ demographic and medical 
information is presented in Table 1. On average, cancer patients were 29.33 (SD = 6.17) years 
old. A third [57 out of 177] of responders were in active treatment at the time of the study, 14% 
[24 out of 177] completed treatment within the previous 6 months, and 54% [96 out of 177] 
completed their cancer treatment more than 6 months ago. Of the latter, 14 (15%)  individuals 
were still taking immunosuppressive medication. 
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[INSERT TABLE 1: Demographic and Medical information of participants] 
 
COVID-19 impact on cancer care 
Forty-five percent [79 out of 177] of AYA cancer patients reported that COVID-19 had 
an impact on their cancer treatment or care, and 21% [38 out of 177] reported no impact at the 
time, but worried that there might be.  
According to the short answers, the analyses revealed six categories of most commonly 
reported changes in cancer care. These categories were: follow-up appointments being 
postponed or cancelled, appointments carried out over the phone or virtually, cancer treatment 
and/or surgery being postponed, having to be alone during the treatment, reduced access to 
medicine, and changes in treatment protocols, such as reduced blood-work or oral instead of 
intravenous chemotherapy. 
 
COVID-19 impact on psychological well-being 
Over a third of AYA participant scored in the clinical range for psychological distress. 
Individuals undergoing treatment or within 6 months of treatment completion, on average, 
reported higher levels of psychological distress. Symptoms of anxiety were more common than 
depressive symptomatology. The mean scores and proportions of participants scoring in the 
clinical range of psychological distress are reported in Table 2.  
Additionally, participants were asked how they felt compared to before the pandemic. 
Sixty-two percent [109 out of 177] of respondents reported feeling more anxious than before, 
34% [52 out of 177] reported feeling the same, and 9% [16 out of 177] reported feeling less 
anxious than before. The proportion of individuals feeling more anxious was the same for those 
currently in treatment, as well as those who have completed treatment over 6 months ago (see 
Supplementary material). 
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[INSERT TABLE 2: Psychological distress among AYAs] 
 
 
The short responses revealed that the most common concerns among the AYAs related 
to COVID-19 and their health status were not being sure how big of a risk COVID-19 posed 
for them, how their body would react to the infection, anxiety about experiencing serious 
complications if they were to catch the virus, and having their cancer care delayed. However, 
individuals also reported impact on mood, as well as worries about their family members, 
returning to “the normal” and finances. The categories and examples of participants’ responses 
can be viewed in Table 3. 
 
[INSERT TABLE 3: Categories of content on COVID-19 impact on psychological wellbeing] 
 
 
Moreover, physical distancing measures imposed by many authorities resulted in social 
isolation with 52% [90 out of 173] of AYAs reported feeling more isolated than prior to the 
pandemic. On the other hand, 39% [68 out of 173] reported feeling about the same, and 9% 
[15 out of 173] reported feeling less isolated than before, and better understood by their friends 
and family. 
“Even though I am still as isolated as I was when going through treatment and 
recovery, I find I feel less isolated than before because now my friends and family understand 
a lot better how it feels.” 
 
The qualitative responses highlighted that despite an increase in social interactions 
online, many individuals missed a more intimate human connection with others. While a few 
individuals reported having more time for themselves and their families, others reported that 
the isolation made them more anxious, depressed, and claustrophobic. Their needs as cancer 
patients were felt to have become secondary: 
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“People are so concerned with COVID-19 that they don’t care about my cancer 
anymore.”  
 
 For some, isolation also acted as a trigger, reminding them of their cancer: 
 
“It makes me feel like I am in the first steps of my treatment all over again.”  
 
COVID-19 information resources and satisfaction 
Participants were asked what sources they relied on for obtaining information related 
to the COVID-19 pandemic. The majority of respondents [159 out of 172] relied on a minimum 
of 2 different sources, with the general news being most read [135 out of 172], followed by 
social media [used by 109 out of 172]. Less than a third [46 out of 172] relied on cancer support 
groups and patient organizations for COVID-19 specific information. Individuals in different 
illness phases reported relying on the same information resources. Satisfaction and 
trustworthiness of the available information related to COVID-19 were perceived to be 
moderate, 6.2/10 and 6.1/10 respectively, with individuals currently undergoing treatment 
reporting least satisfaction and trustworthiness for the available information (see 
Supplementary material for breakdown by treatment status). 
 
Only 24% [42 out of 173] of respondents reported receiving direct communication 
regarding COVID-19 from their oncologists or health care teams, majority (64%) of whom was 
undergoing treatment at the time of this study. Over half of the participants, 56% [96 out of 
170] reported wanting more information about how to cope with the pandemic (see 
Supplementary material for breakdown by treatment status). Furthermore, 35% [60 out of 172] 
COVID-19 IMPACT ON AYA CANCER 
 
 11 
of AYAs would have preferred information about COVID-19 tailored to their needs as young 
cancer patients and survivors. 
 
“It would be nice to have something to read designed with me in mind.” (Female, 32) 
 
On the other hand, a few individuals reported that having more information would be 
overwhelming, and some reported the need for information specifically for mental health 
resources for cancer patients during a pandemic.  
 
Discussion 
Evidence to-date suggests that young people are at lower risk for contracting the novel 
SARS-CoV-2 virus or developing serious complications from it,4,28 however, youth living with 
and beyond cancer might be at an increased risk because due to the compromised immunity 
resulting from illness and/or cancer late-effects.5,29 Moreover, changes in cancer care protocols 
may increase the levels of anxiety and uncertainty not only for those undergoing active 
treatment, but also for individuals in the long-term care. Our cross-sectional study of youth 
living with and beyond cancer, conducted in the initial weeks of the COVID-19 pandemic, 
found that 3 in 10 AYAs experienced increased levels of psychological distress, with anxiety 
being more prominent than depressive symptomatology. As many as 6 in 10 AYAs reported 
feeling more anxious during the COVID-19 pandemic than they had been previously.   
 
Higher levels of distress during a pandemic outbreak might be expected14 and a variety of 
psychological problems such as panic disorder, anxiety, and depression due to COVID-19 
pandemic have already been observed in general population.30 It may be that this is 
compounded for cancer patients, given the salience of risks to their health and their 
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vulnerability due to immunosuppression. The themes driving anxiety and worry for our 
participants were predominantly related to physical health and cancer-related concerns. A 
recent study of Italian adolescent cancer patients and survivors revealed that both groups 
worried about contracting the virus, and felt personally at risk for severe complications, with 
survivors reporting more worry than those in follow up care.31 When stratified by treatment 
status, our results revealed the highest levels of anxiety in those who have completed treatment 
within the past 6 months, followed by those in treatment at the time of the study. We speculate 
that this may in part be due to the uncertainty often experienced upon treatment completion, 
when individuals often have to wait for scans before remission can be confirmed. These 
treatment transitions can be burdensome for patients.9,32 The first few months after treatment 
are also often marked by frequent follow up appointments, all of which were likely postponed 
or cancelled due to the current pandemic. The added uncertainty is likely to contribute to 
anxiety symptoms. 
The lowest levels of clinically elevated psychological distress were present in those off 
treatment, for whom the care was also least impacted by the pandemic and associated events. 
Nevertheless, a high proportion of those off treatment also reported feeling more anxious now 
than compared to the times prior the pandemic. 
The social impact of the disease containment measures has been considerable. Most 
governments and authorities across the world have imposed physical distancing as a way to 
slow the spread of the virus within communities. For many, these measures resulted in social 
isolation, which can result in increased feelings of loneliness and further contribute to the 
feelings of low mood and anxiety.33 The majority of our participants recounted being familiar 
with isolation measures due to their cancer experience. For some AYAs, de novo isolation 
acted as a negative reminder of their illness, while on the other hand, almost 10% reported 
feeling less anxious and isolated compared to the time prior the pandemic. The qualitative 
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responses revealed that this may be due to the fact that they felt better understood, spent more 
time with their families, or even found more time for themselves.  
Research to date suggests that AYAs with cancer like to be involved in their care and need 
tailored, age-appropriate information about their cancer, care, late-effects, and resources.34,35 
Only a quarter of our participants reported receiving direct communication related to COVID-
19 from their health care providers and we demonstrated that more than half of AYAs would 
like to have received more information on how to cope during the COVID-19 pandemic, 
specifically, information tailored to them as young cancer patients and survivors. Regardless 
of the time passed since diagnosis, the most common worry was knowing the extent of the risk 
for contracting the virus and how their body would react if they were to contract the infection. 
Unlike Italian adolescents,31 our AYA participants consumed most of the news related to 
the pandemic via general news sources, followed by social media outlets. This difference may 
be due to the older age of our sample. The fact that AYAs received most information from 
general news sources could also explain the reported need for more tailored information. The 
utility of social media as a way to deliver reliable information, as well as interventions to AYA 
cancer communities is gaining traction and could pave the way for an eHealth approach to 
oncological AYA care.36 Preliminary evidence supports the feasibility and acceptability of 
online psychosocial interventions for AYAs in treatment37 or early post-treatment phases,38 
however, future research should carefully evaluate if online support and digital approaches to 
care respond equally well to the needs of AYAs living with and beyond cancer.   
 
Strengths and Limitations 
While the global reach and early data collection add the largest contribution to the growing 
body of knowledge about the COVID-19 pandemic, there are several limitations that limit the 
generalizability of our work. Our sample size was relatively small, highly heterogeneous, 
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mostly female, and with most responses submitted from North America and Europe. While a 
geographically diverse sample offers broad and preliminary insights into COVID-19 related 
concerns of AYAs globally, it also limits generalizability due to the diverse health care 
systems, time-lags between peaks of the pandemic across different countries, and measures 
taken to prevent the spread of COVID-19.  
Participants were a self-selected group who responded to the online study post, and we 
collected only minor, though relevant details relating to their medical and cancer history. 
Moreover, the survey was cross-sectional in nature and psychological distress was assessed 
using a very brief measure, and relied on short answer questions, to which many individuals 
provided responses with limited context and detail. We relied on retrospective self-report of 
changes in psychological distress since the advent of COVID-19, which are subject to reporting 
biases. Nevertheless, have provided important preliminary evidence, which offers invaluable 
directions for the future research on the impact of COVID-19, and also captured the 
experiences of this vulnerable population in the early weeks of the COVID-19 pandemic. Our 
sample included respondents at different stages of cancer treatment and beyond.  
 
Clinical implications 
The COVID-19 pandemic is rapidly evolving, and we learn new details every day. Even 
though the disruptions in our daily routines and health care systems pose many challenges, 
therein lie many opportunities for improvement of AYA cancer care in the future. The current 
situation highlights the continued need to screen for psychological distress and attend to those 
who might be experiencing distress even under normal circumstances. Finding ways of doing 
this whilst providing follow-up care remotely is particularly important within the current ways 
of working, and the brief PHQ-4 used in this study may offer a promising way to monitor 
psychological distress in clinical contexts.  
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The health care teams should actively engage and provide relevant and reliable information 
about COVID-19 for cancer patients and survivors, as well as information about any mental 
health resources. This will be important as the lockdown measures begin to ease in the coming 
months. Individuals whose care was delayed should receive adequate support so that they 
follow through with their appointments and continue the necessary treatment. While attending 
to those who are undergoing treatment or just recently completed it has been a priority, our 
results emphasize that the needs of long-term survivors should not be overlooked, as many may 
be experiencing higher levels of distress due to their illness history. 
Telemedicine and eHealth might offer a favorable approach for some AYAs, however, in 
scaling them up, we have to ensure we do not leave behind those with limited access to digital 
technologies. 
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Figure 1: Global and UK COVID-19 context at the time of this study. 
This figure aimed at providing future readership with COVID-19 context at the time of writing 
(May 12, 2020). By mid-March, most countries across Europe began nation-wide lockdowns. 
At the beginning of April, most cancer centers began adapting their treatment protocols. By 
late April COVID-19 a Cancer Consortium Registry was established with currently over 100 
participating institutions globally reporting results about COVID-19 outcomes in cancer 
patients. There are currently several vaccine trials which have already began testing in healthy 
human participants.  
 
 
Table 1 
Demographic and Medical information of participants 
 
 Variable n % M (SD) Range 
 
 Age 177 100 29.33 (6.17) [18 - 39] 
Gender 
 Female 154 87 
 Male 20 11 
 Prefer not to answer 3 2 
Region 
 North America 93 53 
 Central and South America 2 1 
 Europe 78 44 
 Middle East 1 1 
Mar 16 Mar 18 Mar 21 Apr 9 Apr 17 Apr 21 Apr 28 Apr 29
UK government advises
social distancing
UK government issues new advice for
vulnerable groups (incl. cancer patients)
Shielding measures 
introduced
National Health Service (NHS) updates advice 
and support for people with cancer
Cancer Research UK declares that   
cancer care needs mass COVID-19 testing
UK government announces the
expansion of COVID-19 testing
Dec 31
China reports several pneumonia
cases of uknown etimology to WHO
Jan 7
Novel SARS-CoV-2 virus
identified
Jan 30
WHO issues ‘public health 
emergeny of international concern’ alert
Mar 11
WHO declares COVID-19  a global pandemic
2019 2020
Jan 11
First death linked to
COVID-19 reported in Wuhan
May 12
Jan 13
First COVID-19  case reported 
outside China (Thailand)
Feb 21 Apr 2
More than 1 million COVID-19 
cases are reported worldwide
Apr 10
Apr 23
COVID-19 global death
toll top 100,000
Oxford University initiate clinical trials 
for a COVID-19 vaccine candidate ChAdOx1 nCoV-19
National Institutes of Health (NIH) initiates
first clinical trial in the U.S. (remdesivir)
Lockdown measures 
beginning to ease  in some 
EU member states
Urgent cancer referrals stop
COVID-19 and  
cancer in the UK:
Apr  6 May 11
PRESENT STUDY’s DATA COLLECTION
Apr 21
COVID-19 and Cancer Consortium 
Registry (CCC19) established
2020
Most countries across EU 
enter lockdown
Mar 15
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 Africa 0 0 
 Asia 1 1 
 Oceania 3 2 
Living arrangement 
 Alone 24 14 
 Shared house 13 7 
 Partner only 45 25 
Parents                 20        11  
Family                  72        41 
 Other 4 2 
Treatment status 
 Undergoing treatment 57 32 
 Completed within 6 months 24 14 
 Completed more than 6 months ago 96 54 
Immunosuppressant medications 
 Yes 41 23 
 No 122 69 
 Prefer not to answer 14 8 
Table 1 continued 
Variable n % M (SD) Range 
             
Mental health diagnosis 
 
Yes 66 37 
  
No 108 61   
Prefer not to answer 3 2   
 
Table 2 
Psychological distress among AYAs 
 
 n           M (SD) M (SD) M (SD) 
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Total sample 177 2.61 (1.94) 1.92 (1.71) 4.53 (3.29) 
Undergoing treatment 57 2.84 (1.89) 2.07 (1.69) 4.91 (3.22) 
Completed within 6 months 24 3.54 (2.02) 2.29 (1.90) 5.83 (3.60) 
Completed more than 6 months ago 96 2.24 (1.87) 1.73 (1.66) 3.97 (3.15) 
 
 n n (%) n (%) n (%) 
Total sample 177 56 (32%) 34 (19%) 51 (29%) 
Undergoing treatment 57 20 (35%) 10 (18%) 17 (30%) 
Completed within 6 months 24 12 (50%) 6 (25%) 12 (50%) 
Completed more than 6 months ago 96 24 (25%) 18 (19%) 22 (23%) 
Note. PHQ-4 items are rated on a 4-point Likert scale ranging from 0 to 3. The upper half of 
the table contains means and SD, while the bottom half contains number and proportion of 
individuals scoring in the clinical range. 
 
Category Definition Example 
General anxiety Broad statements and 
descriptions of anxiety and 
worries that are not specified 
or described in detail 
“My anxiety levels tend to 
be quite high.  I had felt like 
I had my anxiety under 
control, but this situation 
has thrown me off.” 
Health anxiety Broad statements about 
worries of own health, 
hypochondria, includes 
concerns about individuals’ 
mental health and illness 
triggers 
“I worry that my current 
health problems will not be 
taken as seriously in the 
healthcare system as they 
were before.” 
Loneliness Mentions of lacking support, 
feeling low and sad due to 
isolation, feelings of 
loneliness 
“Whereas I was isolated 
prior to the global 
lockdown, I was still able to 
have the physical support of 
my family given that they 
were healthy. I have now 
lost that, making navigating 
cancer treatment all the 
more lonely.” 
 
Low mood Broader descriptions of low 
mood or morale, depression 
“Increased feelings of 
depression and overeating.” 
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Disruptions Refers to the impact on 
mental health and wellbeing 
due to disruptions in daily 
living and activities 
“My biggest source of 
happiness was my job and 
not being able to see my 
students is heartbreaking.” 
Death/dying Explicit mentions about 
dying and mortality 
“I am constantly worried 
that if I fall sick, I will end 
up dying considering my 
cancer history and weak 
immune system.” 
Worry about COVID-19 – 
self  
Worries about how one’s 
body would react to 
COVID-19, worries about 
severe complications due to 
COVID-19, including 
worries about receiving 
adequate care if they 
contracted COVID-19 
“I am worried that if I 
caught it, I would be one of 
the ones that do not do well 
as I have had radiation to 
my spleen and still have low 
lymphocytes.” 
Worry about COVID-19 – 
others  
Worries about close 
individuals or family 
members contracting the 
virus  
“Mostly worried about 
family/elder members of the 
family wanting to get outside 
more.” 
Cancer care Changes and disruptions in 
cancer care, which are 
unfavorable; worry about 
continuing with care and 
going to the hospital where 
many people are infected 
“I worry about what stage 
my cancer will be when they 
are finally able to do my 
surgery/treatment.” 
 
Return to normal Concerns about how to 
return to normal, what 
normal will look like; 
worries about returning back 
to work  
“Going back to work 
eventually stresses me.” 
Finance Direct financial impact from 
job loss or disruption; loss 
of insurance 
“I have lost my job, risk 
losing my insurance, and 
will be in active treatment 
until late summer.” 
Table 3: Categories of content on COVID-19 impact on psychological wellbeing 
 
 
SUPPLEMENTARY MATERIAL – Breakdown by treatment phase 
 Better than before 
N (%) 
Same as before  
N (%) 
More anxious than 
before 
N (%) 
Undergoing 
treatment (n = 57) 
7 (12%) 14 (25%) 36 (63%) 
Completed within 6 
months (n = 24) 
2 (8%) 9 (38%) 13 (54%) 
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Completed more 
than 6 months ago 
(n = 96) 
7 (7%) 29 (30%) 60 (63%) 
Table 1: Table showing the proportion of individuals feeling more anxious or distressed now, 
compared to the time prior to the pandemic, stratified by treatment phase 
 
 Received info about 
COVID 
N (%) 
Did not receive info about 
COVID 
N (%) 
Undergoing treatment (n = 
57) 
27 (47%) 30 (53%) 
Completed within 6 
months (n = 23) 
4 (17%) 19 (83%) 
Completed more than 6 
months ago (n = 91) 
11 (10%) 82 (90%) 
Table 2: Table showing the proportion of individuals who received direct communication 
about COVID-19 from the health care team by treatment phase 
 
 Want more 
information 
N (%) 
Don’t want more 
information 
N (%) 
Not sure 
N (%) 
Undergoing 
treatment (n = 56) 
33 (59%) 13 (23%) 10 (18%) 
Completed within 6 
months (n = 23) 
13 (57%) 4 (17%) 6 (26%) 
Completed more 
than 6 months ago 
(n = 91) 
50 (55%) 16 (18%) 25 (27%) 
Table 3: Table showing the proportion of individuals who would have wanted more 
information about COVID-19, stratified by treatment phase 
 
 COVID-19 
Information sources 
 
Satisfaction 
(mean) 
Trustworthiness 
(mean) 
Undergoing 
treatment (n = 57) 
General news (n = 
44) 
Medical 
Professionals (n = 
43) 
Social Media (n = 
37) 
6/10 5.8/10 
Completed within 6 
months (n = 23) 
General news (n = 
22) 
6.3/10 6.5/10 
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Medical 
Professionals (n = 
14) 
Social Media (n = 
12) 
Completed more 
than 6 months ago 
(n = 91) 
General news (n = 
69) 
Social Media (n = 
60) 
Medical 
Professionals (n = 
44) 
6.3/10 6.2/10 
Table 4: Table showing the most commonly used information resources for COVID-19, and 
reported satisfaction and perceived trustworthiness of these resources, stratified by treatment 
phase 
NOTE: Satisfaction and trustworthiness are rated on a scale from 0 (least 
satisfied/trustworthy) to 10 (most satisfied/trustworthy). 
 
 
 
 
 
